UBE2G1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.244800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.217600E-01
Normal-vs-Stage2
2.006400E-01
Normal-vs-Stage3
6.678200E-02
Normal-vs-Stage4
3.684000E-01
Stage1-vs-Stage2
9.677400E-01
Stage1-vs-Stage3
2.129000E-01
Stage1-vs-Stage4
9.088600E-01
Stage2-vs-Stage3
2.266600E-01
Stage2-vs-Stage4
9.300600E-01
Stage3-vs-Stage4
2.700800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.161000E-01
Normal-vs-AfricanAmerican
8.190200E-01
Normal-vs-Asian
1.262970E-01
Caucasian-vs-AfricanAmerican
1.855430E-01
Caucasian-vs-Asian
3.512800E-01
AfricanAmerican-vs-Asian
1.089410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.194000E-01
Normal-vs-Female
2.440600E-01
Male-vs-Female
5.303000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.924200E-01
Normal-vs-Age(41-60Yrs)
5.219600E-01
Normal-vs-Age(61-80Yrs)
1.397240E-01
Normal-vs-Age(81-100Yrs)
2.049600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.518000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.346000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.629200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.803110E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.407200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.727000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.414440E-01
Normal-vs-Daily Drinker
3.746300E-02
Normal-vs-Weekly Drinker
2.524200E-01
Normal-vs-Occasional Drinker
3.492600E-01
Normal-vs-Social Drinker
6.252400E-01
Non Drinker-vs-Daily Drinker
5.838600E-01
Non Drinker-vs-Weekly Drinker
7.318600E-01
Non Drinker-vs-Occasional Drinker
1.733240E-01
Non Drinker-vs-Social Drinker
1.343360E-01
Daily Drinker-vs-Weekly Drinker
4.066200E-01
Daily Drinker-vs-Occasional Drinker
4.312200E-02
Daily Drinker-vs-Social Drinker
7.749600E-02
Weekly Drinker-vs-Occasional Drinker
4.189600E-01
Weekly Drinker-vs-Social Drinker
3.478400E-01
Occasional Drinker-vs-Social Drinker
7.158000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.809800E-01
Normal-vs-Grade 2
9.370800E-01
Normal-vs-Grade 3
9.396800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.916800E-01
Grade 1-vs-Grade 3
3.915600E-01
Grade 1-vs-Grade 4
8.809800E-01
Grade 2-vs-Grade 3
9.522000E-01
Grade 2-vs-Grade 4
9.370800E-01
Grade 3-vs-Grade 4
9.396800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.784040E-01
Normal-vs-NonDiabetic
1.759200E-01
Diabetic-vs-NonDiabetic
6.799800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.969400E-01
Normal-vs-NoPancreatitis
1.837610E-01
Pancreatitis-vs-NoPancreatitis
9.056200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.865800E-01
Normal-vs-N1
1.665190E-01
N0-vs-N1
5.141200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.309630E-01
Normal-vs-TP53-NonMutant
6.357400E-01
TP53-Mutant-vs-TP53-NonMutant
9.103700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
